Sutro Biopharma Inc (STRO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sutro Biopharma Inc (STRO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10856
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sutro Biopharma Inc (Sutro Biopharma), formerly Fundamental Applied Biology Inc, discovers, develops and manufactures novel cancer medicines which include antibody-drug conjugates (ADC’s), bispecific antibodies, and antibody-based therapeutics targeting immuno-oncology pathways. Its pipeline portfolio includes STRO-001, a CD74 ADC for the treatment of multiple myeloma, lymphomas, diffuse large B-cell lymphoma (DLBCL) and Mantle cell lymphoma (MCL); STRO-002, targeting ovarian and endometrial cancer. The company develops its pipeline products through Xpress CF platform, a biochemical protein synthesis system which develops therapeutic proteins and discovers drugs for the treatment and prevention of diseases. Sutro Biopharma owns a manufacturing facility in San Carlos, California. The company works in partnership with various pharmaceutical and biotechnology companies for pre-clinical development of novel antibody drug conjugates. Sutro Biopharma is headquartered in South San Francisco, California, the US.

Sutro Biopharma Inc (STRO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sutro Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Sutro Biopharma Raises USD85.4 Million in Series E Financing 11
Sutro Biopharma Raises USD60 Million in Venture Financing 13
SutroVax Raises Funds Through Initial Financing Round 14
Sutro Biopharma Raises US$26 Million In Series D Financing 15
Sutro Biopharma Raises US$16.5 Million In Second Tranche Of Series C Financing 17
Partnerships 19
Sutro Biopharma and Leukemia & Lymphoma Society Enter into Partnership 19
Sutro Biopharma Amends Co-Development Agreement with Celgene 20
Sutro Biopharma Enters into Agreement with University of California, San Francisco 22
Sutro Biopharma Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 23
Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 24
Sutro Biopharma Enters Into Co-Development Agreement With Celgene 25
Licensing Agreements 26
Merck Enters into Licensing Agreement with Sutro Biopharma 26
EnWave Enters into License Agreement with Sutro Biopharma for powderREV Technology 27
EMD Serono Enters into Licensing Agreement with Sutro Biopharma 28
Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 29
Equity Offering 30
Sutro Biopharma Prices IPO of Shares for USD85 Million 30
SutroVax Spins Out from Sutro Biopharma 31
Sutro Biopharma Inc – Key Competitors 32
Sutro Biopharma Inc – Key Employees 33
Sutro Biopharma Inc – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Financial Announcements 35
Nov 14, 2018: Sutro Biopharma announces third quarter 2018 financial results 35
Corporate Communications 37
Nov 08, 2018: Sutro appoints industry veteran Shalini Sharp to board of directors 37
Sep 12, 2018: Sutro Biopharma names Worsley as Chief Business Officer and Linda Fitzpatrick as People and Communications Chief 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sutro Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sutro Biopharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sutro Biopharma Raises USD85.4 Million in Series E Financing 11
Sutro Biopharma Raises USD60 Million in Venture Financing 13
SutroVax Raises Funds Through Initial Financing Round 14
Sutro Biopharma Raises US$26 Million In Series D Financing 15
Sutro Biopharma Raises US$16.5 Million In Second Tranche Of Series C Financing 17
Sutro Biopharma and Leukemia & Lymphoma Society Enter into Partnership 19
Sutro Biopharma Amends Co-Development Agreement with Celgene 20
Sutro Biopharma Enters into Agreement with University of California, San Francisco 22
Sutro Biopharma Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 23
Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 24
Sutro Biopharma Enters Into Co-Development Agreement With Celgene 25
Merck Enters into Licensing Agreement with Sutro Biopharma 26
EnWave Enters into License Agreement with Sutro Biopharma for powderREV Technology 27
EMD Serono Enters into Licensing Agreement with Sutro Biopharma 28
Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 29
Sutro Biopharma Prices IPO of Shares for USD85 Million 30
SutroVax Spins Out from Sutro Biopharma 31
Sutro Biopharma Inc, Key Competitors 32
Sutro Biopharma Inc, Key Employees 33
Sutro Biopharma Inc, Other Locations 34

List of Figures
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Sutro Biopharma Inc (STRO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tata Motors Ltd (TATAMOTORS):企業の財務・戦略的SWOT分析
    Tata Motors Ltd (TATAMOTORS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ewopharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Ewopharma AG (Ewopharma) is a pharmaceutical company that provides registration and marketing of pharmaceuticals and consumer health products. The company provides services such as market evaluation, marketing services, regulatory affairs, licensing, pharmacovigilance, and others. It offers …
  • Philippine Long Distance Telephone Co (TEL):企業の財務・戦略的SWOT分析
    Philippine Long Distance Telephone Co (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • CS Energy Ltd:企業の戦略的SWOT分析
    CS Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Kyowa Hakko Kirin Co., Ltd.:企業のM&A・事業提携・投資動向
    Kyowa Hakko Kirin Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kyowa Hakko Kirin Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Tanita Corp:企業の戦略的SWOT分析
    Tanita Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • AiCuris GmbH & Co KG-製薬・医療分野:企業M&A・提携分析
    Summary AiCuris GmbH & Co KG (AiCuris), a subsidiary of Santo Holding AG is a drug development company that discovers and develops antibacterial and antiviral agents for the treatment of life-threatening infectious diseases. The company’s pipeline products include antiviral and antibacterial agents …
  • Coca-Cola Bottling Co. Consolidated (COKE):企業の財務・戦略的SWOT分析
    Coca-Cola Bottling Co. Consolidated (COKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Ambac Financial Group, Inc.:企業の戦略・SWOT・財務分析
    Ambac Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ambac Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Suncor Energy Inc (SU)-エネルギー分野:企業M&A・提携分析
    Summary Suncor Energy Inc. (Suncor) is an integrated energy company that mainly focuses on the development of Athabasca oil sands. It carries out development and up gradation of oil sands; offshore and onshore oil and gas production; refining of crude oil and marketing of petroleum and petrochemical …
  • Yanlord Land Group Ltd:企業の戦略・SWOT・財務分析
    Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • NeuroScientific Biopharmaceuticals Ltd (NSB):企業の財務・戦略的SWOT分析
    NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • MetGen Oy:製薬・医療:M&Aディール及び事業提携情報
    Summary MetGen Oy (MetGen) is a manufacturer and distributor of enzymatic solutions. The company offers metzyme, an industrial and natural catalysts used for accelerating chemical reactions. Its enzymatic solutions find applications in various processes such as mechanical processes, lignocellulosic …
  • Alzinova AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Alzinova AB (Alzinova) is a pharmaceutical company that discovers and develops therapeutics for the treatment of Alzheimer’s disease. The company develops amyloid beta CC peptide technology, which offers long-term research and development capabilities including the discovery and development …
  • Federal Signal Corporation:企業の戦略・SWOT・財務情報
    Federal Signal Corporation - Strategy, SWOT and Corporate Finance Report Summary Federal Signal Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Tecan Group Ltd (TECN):医療機器:M&Aディール及び事業提携情報
    Summary Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation sup …
  • The Aerospace Corp:企業の戦略的SWOT分析
    The Aerospace Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Top Glove Corporation Berhad (TOPGLOV):医療機器:M&Aディール及び事業提携情報
    Summary Top Glove Corporation Berhad (Top Glove) is a manufacturer and distributor of rubber gloves. The company’s products include nitrile gloves, vinyl gloves, latex gloves, surgical gloves, clean room gloves, household gloves, polyisoprene gloves, and cast polyethylene gloves. It also provides th …
  • Relation Insurance Services, Inc:企業の戦略・SWOT・財務情報
    Relation Insurance Services, Inc - Strategy, SWOT and Corporate Finance Report Summary Relation Insurance Services, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Sosei Group Corp (4565):製薬・医療:M&Aディール及び事業提携情報
    Summary Sosei Group Corp (Sosei) is a biopharmaceutical company that develops and commercializes drugs. The company’s pipeline products include NorLevo, NVA237, QVA149 and SO-1105. Its NorLevo product is an oral emergency contraceptive; and SO-1105 is an antifungal agent, administered as a muco-adhe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆